Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

Cung, T.; Morel, O.; Cayla, G.; Rioufol, G.; Garcia-Dorado, D.; Angoulvant, D.; Bonnefoy-cudraz, E.; Guérin, P.; Elbaz, M.; Delarche, N.; Coste, P.; Vanzetto, G.; Metge, M.; Aupetit, J.; Jouve, B.; Motreff, P.; Tron, C.; Labèque, J.; Steg, P.; Cottin, Y.; Rangé, G.; Clerc, J.; Claeys, M.; Coussement, P.; Prunier, F.; Moulin, F.; Roth, O.; Belle, L.; Dubois, P.; Barragan, P.; Gilard, M.; Piot, C.; Colin, P.; de Poli, F.; Morice, M.; Ider, O.; Dubois-Randé, J.; Unterseeh, T.; le Breton, H.; Béard, T.; Blanchard, D.; Grollier, G.; Malquarti, V.; Staat, P.; Sudre, A.; Elmér, E.; Hansson, M.; Bergerot, C.; Boussaha, I.; Jossan, C.; Derumeaux, G.; Mewton, N.; Ovize, M.

doi:10.1056/NEJMoa1505489

Public

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

Shared by NobleBlocks on Sep 9, 2015 • 12:00 AM UTC

Authors:

T. Cung

O. Morel

G. Cayla

Abstract

BACKGROUND Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling. METHODS In a multicenter, double-blind,...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!